Alan Wilhelm
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
-
- Cancer therapeutics and mechanisms 7
- Chemical Synthesis and Analysis 2
- Oncology 12
- HER2/EGFR in Cancer Research 11
- CAR-T cell therapy research 2
- Co-authors
- Ravi Chari (11 shared papers)Yelena Kovtun (7 shared papers)Nicholas C. Yoder (7 shared papers)Erin K. Maloney (11 shared papers)Chen Bai (7 shared papers)Lauren Harvey (6 shared papers)Jan Pinkas (5 shared papers)Victor S. Goldmacher (3 shared papers)
- Journals
- Blood (6 papers)Cancer Research (4 papers)Molecular Cancer Therapeutics (2 papers)Molecular Pharmaceutics (2 papers)ACS Medicinal Chemistry Letters (2 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Alan Wilhelm
21 papers receiving 402 citations
Peers
Comparison fields: 5 of 40
- Oncology 285
- Hematology 99
- Radiology, Nuclear Medicine and Imaging 171
- Dermatology 29
- Immunology 52
Countries citing papers authored by Alan Wilhelm
This map shows the geographic impact of Alan Wilhelm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Wilhelm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Wilhelm more than expected).
Fields of papers citing papers by Alan Wilhelm
This network shows the impact of papers produced by Alan Wilhelm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Wilhelm. The network helps show where Alan Wilhelm may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Wilhelm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 137 | |
| 2 | 2016 | 75 | |
| 3 | 2019 | 41 | |
| 4 | 2019 | 33 | |
| 5 | 2014 | 29 | |
| 6 | 2019 | 23 | |
| 7 | 2016 | 14 | |
| 8 | 2019 | 12 | |
| 9 | 2019 | 11 | |
| 10 | 2023 | 10 | |
| 11 | 2023 | 7 | |
| 12 | 1995 | 7 | |
| 13 | 2017 | 6 | |
| 14 | 2019 | 5 | |
| 15 | 2014 | 5 | |
| 16 | 2016 | 5 | |
| 17 | 2013 | 3 | |
| 18 | 2015 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2015 | 1 |
About Alan Wilhelm
Alan Wilhelm is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Immunology, having authored 22 papers that have together received 427 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (11 papers), Cancer therapeutics and mechanisms (7 papers), Synthesis and pharmacology of benzodiazepine derivatives (5 papers), Click Chemistry and Applications (2 papers), Chemical Synthesis and Analysis (2 papers), CAR-T cell therapy research (2 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Oncology (285 citations), Hematology (99 citations), Radiology, Nuclear Medicine and Imaging (171 citations), Dermatology (29 citations) and Immunology (52 citations). Alan Wilhelm has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Ravi Chari, Yelena Kovtun, Nicholas C. Yoder, Erin K. Maloney, Chen Bai, Lauren Harvey, Jan Pinkas, Victor S. Goldmacher, Sharlene Adams and Charlene A. Audette. Their work appears in journals such as Blood, Cancer Research, Molecular Cancer Therapeutics, Molecular Pharmaceutics and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.